🇺🇸 FDA
Patent

US 7485306

Lutzomyia longipalpis polypeptides and methods of use

granted A61KA61K2039/53A61K2039/57

Quick answer

US patent 7485306 (Lutzomyia longipalpis polypeptides and methods of use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Feb 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/53, A61K2039/57, A61K2039/575, A61K2039/58